US FDA issues warning letter to Lupin for Maharashtra-based API plant Press Trust of India Nov 3, 2022 The FDA inspected the manufacturing facility from 22nd March to 4th April, 2022
Lupin’s Goa manufacturing plant gets EIR from US FDA EP News Bureau Dec 14, 2021 FDA changes inspection classification of the facility to Voluntary Action Indicated (VAI)
